Page 225 - Multidisipliner Covid 19

COVID-19 Tedavi Stratejileri

blockade for severe COVID-19. medrxiv. 2020;04(20):20061861.
56. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness
of convalescent plasma and hyperimmune immunoglobulin for the
treatment of severe acute respiratory infections of viral etiology: a
systematic review and exploratory meta-analysis. J Infect Dis. 2015;
211(1):80–90.
57. Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy
in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020; 202004168.
58. Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with
COVID-19 with convalescent plasma. JAMA. 2020;323(16): 1582–89.
59. Ahn JY, Sohn Y, Lee SH, et al. Use of convalescent plasma therapy in
two COVID-19 patients with acute respiratory distress syndrome in
Korea. J Korean Med Sci. 2020;35(14):e149.
60. Zhang B, Liu S, Tan T, et al. Treatment with convalescent plasma for
critically ill patients with SARS_CoV_2 infection. Chest.2020;S0012_
3692(20):30571_30577.
61. COVID-19 Treatment Guidance Writing Group [Internet]. JHMI clinical
guidance for available pharmacologic therapies 2020 [erişim 25 Mart
2020]. https://www.hopkinsguides.com/hopkins/view/Johns_Hop-
kins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_.
62. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvas-
cular injury and thrombosis in the pathogenesis of severe COVID-19
infection: a report of five cases. Transl Res. 2020; S1931-5244(20):30070-
0. doi: 10.1016/j.trsl.2020.04.007.
63. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboem-
bolism in patients with severe novel coronavirus pneumonia. J Thromb
Haemost. 2020. https://doi.org/10.1111/jth.14830.
64. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment
is associated with decreased mortality in severe coronavirus disease
2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–99.
65. Shi C, Wang C, Wang H, et al. Clinical observations of low molecular
weight heparin in relieving inflammation in COVID-19 patients: A
retrospective cohort study. medrxiv. 2020. https://doi.org/10. 1101/
2020.03.28.20046144.
66. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition
and management of coagulopathy in COVID-19. J Thromb Haemost.
2020;18(5):1023–26.

224